돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 491430생성일: 2026년 10월 26일

Quinoxaline-2-carbaldehyde → 2-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxaline

https://huagongshe.com/reaction/491430

반응식

참여 물질

역할이름HCID투입량
반응물Quinoxaline-2-carbaldehydeHCID 594088—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물HCID 57678297HCID 57678297—
촉매Acetic AcidHCID 176—
용매1,2-DichloroethaneHCID 11—
생성물2-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxalineHCID 1199827755%

반응 단계

The piperazine template (0.075 g, 0.213 mmol) of Example 24 was dissolved in 1,2-dichloroethane (3 mL) and treated with quinoxaline-2-carbaldehyde (0.044 g, 0.277 mmol) and glacial acetic acid (2 drops). Sodium triacetoxyborohydride (0.090 g, 0.426 mmol) was added, and the mixture was stirred at room temperature until the reaction was complete by LCMS analysis. The solvent was removed under reduced pressure, and the resulting residue was purified by RP-HPLC to yield the free base (0.0578 g, 55% yield). MS (ESI) m/z 494.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07531542B2
출처 데이터셋uspto-grants-2009_05
ORD IDord-e55cb59139414209ac3587dd58e64a21
출처 메모uspto-grants-2009_05